Nuclear medicine and radiopharmaceutical manufacturing market is estimated to be more than USD 6 billion in 2030

The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics

SHARE THIS POST :
Nuclear medicine and radiopharmaceutical manufacturing market is estimated to be more than USD 6 billion in 2030 <Roots>

The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharmaceuticals

Roots -ysis is pleased to announce the publication of its recent study, -led, “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030”

For more information please click on the following link:

https://www.roots-ysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

Other Recent Offerings

High Energy Chemistry / Hazardous Chemistry-based API Manufacturing Services Market: Focus on High Temperature, Low Temperature / Cryogenic, High Pressure and Low Pressure Chemistries, 2020-2030

Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030

China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030

Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030

About Roots -ysis

Roots -ysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, -ysis and insights are driven by an experienced leader-p team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@roots-ysis.com

Contact Information

Roots -ysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@roots-ysis.com